Bicycle Therapeutics deal for haemophilia and sickle cell disease therapies could be worth $410 …

Bicycle Therapeutics deal for haemophilia and sickle cell disease therapies could be worth $410 … | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado

The only conference focused solely on the pharmaceutical development of peptide therapeutics.

Bicycle Therapeutics deal for haemophilia and sickle cell disease therapies could be worth $410 …

Peptide News from Biotech and Pharma, Raw News September 13, 2017

Bicycle Therapeutics is developing a new class of medicines to fight cancer and other diseases using its proprietary bicyclic peptide, or 'Bicycle', ...